EDITORIAL
Published on 16 Jul 2024
Editorial: Is there still room for pharmacogenetics in 2023? The cases of infectious diseases and oncology
doi 10.3389/fphar.2024.1457733
- 356 views
- Frontiers in Pharmacology
- Pharmacogenetics and Pharmacogenomics
- Research Topics
- Is there still room for Pharmacogenetics in 2023? The cases of Infectious Diseases and Oncology
Is there still room for Pharmacogenetics in 2023? The cases of Infectious Diseases and Oncology
3,508
Total downloads
12k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 22 Mar 2024
Effect of NAT2, GSTM1 and CYP2E1 genetic polymorphisms on plasma concentration of isoniazid and its metabolites in patients with tuberculosis, and the assessment of exposure-response relationships
doi 10.3389/fphar.2024.1332752
- 1,568 views
- 2 citations
ORIGINAL RESEARCH
Published on 14 Sep 2023
Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece
doi 10.3389/fphar.2023.1248898
- 2,422 views
- 6 citations
REVIEW
Published on 15 May 2023
Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm?
doi 10.3389/fphar.2023.1184523
- 3,211 views
- 9 citations
ORIGINAL RESEARCH
Published on 09 Jan 2023
Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia
doi 10.3389/fphar.2022.980309
- 1,883 views
- 1 citation
Published in
Frontiers in Pharmacology
- Pharmacogenetics and Pharmacogenomics
Participating Journals
Frontiers in Genetics
- 2.8 impact factor
- 5.5 citescore
Impact
- 12kTopic views
- 7,818Article views
- 3,508Article downloads